| Over one million persons are afflicted with bedsores in US hospitals
every year. The problem is growing worse, partly because of an aging population. A radical
departure from present treatment approaches is called for. The cost of bedsores in
hospitals is conservatively 55 billion dollars per year. When patients are hospitalized,
they are prone to have skin breakdown wherever the weight of their body presses into the
bed. They are at greatest risk if they move very little or they are in bed or in a chair
for a long time, especially if they also have been losing weight. Ordinary pressure on the
skin as you sit or move across sheets may be enough to tear or breakdown their skin. It is
worth a great deal of effort to keep skin well-protected; skin breakdown is uncomfortable,
a major indignity, and costly.
Phage Therapy
Etiology: Staphylococcus aureus, Escherichia coli, Klebsiella, Proteus, Pseudomonas
Phage Therapy Center
Phage Therapy Center treats antibiotic-resistant infections. [More information...].
Bed Sore, Male 53 Years
 |
| November 17,
2000 |
 |
| April 10,
2001 |
 |
| April 10,
2001 |
Bed sore patient treated with bacteriophages and PhageBioDerm.
Additional Information About Phage Therapy for This Condition
Hirzfield Institute of Immunology and Virology
Therapeutic
Use of Bacteriophages in Bacterial Infections
Hirzfield Institute of Immunology and Virology
Efficacy of Phage Therapy - Clinical Trials
Evergreen State College
Polish Update
International Journal of Dermatology
A novel sustained-release matrix based on biodegradable poly(ester
amide)s and impregnated with bacteriophages and an antibiotic shows promise in management
of infected venous stasis ulcers and other poorly healing wounds
The Star Ledger
Germs that Fight Germs
The News Sentinel
Rare cure
saves man's foot
CBS News: 48 Hours
Silent
Killers: Fantastic Phages?
Eliava Institute
List of Bacteriophages
Medical Information
The National Decubitis
Foundation
Decubitus
Ulcers
Presse Med.
Clinical efficacy and cost/benefit ratio of current treatment of MRSA
infections in intensive care units |